Cancer is a complex disease that challenges even the most well-versed clinicians. However, clinical technology has become a powerful tool for navigating this complexity. By consolidating vast amounts of oncology-specific data and harnessing advanced algorithms, technology platforms infused with clinical knowledge empower healthcare payers and providers to make well-informed decisions and enhance the quality of care delivered to cancer patients.

Clinically-driven technology enables payers and providers to tap into a wealth of oncology knowledge that is continually updated and changing through the review and incorporation of the latest scientific research, clinical findings, the U. S. Food and Drug Administration (FDA) approvals, and reputable oncology society endorsements. The National Comprehensive Cancer Network (NCCN) is an integral organization that also drives evidence-based treatment regimens for cancer. By aligning with the most current oncology guidelines, the technology ensures that stakeholders stay at the forefront of advancements in cancer care. This dynamic approach supports informed decision-making and enables a more coordinated and collaborative approach between payers and providers, fostering a seamless exchange of information and expertise.

Clinically-driven technology helps payers navigate the intricate landscape of cancer care. Through its sophisticated, proprietary algorithms and data consolidation capabilities, it assists in synthesizing complex information into actionable insights. This empowers payers to quickly and easily validate proposed treatment options and approve member care in an automated manner. By leveraging the power of technology, payers can confidently navigate the complexities of cancer treatment validation, making decisions grounded in evidence and tailored to individual member needs.

The Power of Clinical Expertise
Technology backed by real-life clinical experts serves as a powerful extension of health plan clinical teams. With decades of clinical experience and knowledge, these solutions empower health plans to make intelligent decisions and enable optimal care. This clinical expertise helps health plans tap into the latest research, evidence-based guidelines, and treatment options, offering valuable insights that drive the delivery of high-quality care.

These technology solutions connect the clinical expertise of healthcare professionals with the efficiency and scalability of technology. By leveraging the collective knowledge and experience of clinical experts, health plans can apply critical clinical evidence to their treatment validation processes.

Advertisement #3

Easing Administrative Burdens
Clinical technology is transforming the oncology field by significantly easing administrative burdens for payers and providers. Through streamlined processes, automated tasks, and reduced paperwork, clinical technology frees up valuable time and resources to prioritize optimal member care. By digitizing and automating cancer care prior authorization workflows, healthcare teams can focus on delivering high-quality care rather than being entangled in administrative hurdles. This shift improves efficiency in authorizing cancer care, enhances stakeholder communication, and ultimately improves the overall member experience.

Individualizing Oncology Care
Integrating clinical expertise and technology helps place members at the heart of the treatment journey. By leveraging technology platforms, providers can input member-specific diagnosis data and see all available evidence-based treatment plans for their specific case. This information enables the provider to tailor the treatment plan to the member’s needs, ensuring that care aligns with the rapidly evolving landscape of oncology research. This individualized approach optimizes treatment outcomes, improves patient satisfaction, and empowers members to actively participate in their care.

The platform’s comprehensive knowledge base is continuously updated with the latest scientific research, FDA-approved drugs, NCCN guidelines, and other medical society-endorsed treatments. Clinically-driven technology facilitates the delivery of high-quality, high-value, member-centric care for members with cancer.

Amidst the intricate landscape of cancer, clinically-driven technology emerges as a crucial tool empowering healthcare payers and providers to effectively navigate its multifaceted complexities.

Clinically-driven technology platforms are revolutionizing oncology care by consolidating extensive oncology-specific data, harnessing advanced algorithms, and embracing collaboration. These platforms facilitate shared decision-making, enhance treatment plan validation, individualize care, and alleviate administrative burdens. By embracing clinical expertise and technology, health plans can enable optimal member-centric care grounded in the latest evidence-based guidelines. As we continue to leverage the power of clinical technology, we pave the way for improved outcomes for all stakeholders.

Featured image licensed under the Unsplash+ License

Eviti Connect for Oncology from NantHealth was the first solution of its kind to use state-of-the-art technology leveraging clinical experts to efficiently validate oncology treatment decisions with evidence-based medicine and payer policies before treatment begins. The automated process reduces the administrative time involved in obtaining and providing authorizations, aligning all parties around value-based care. The NantHealth team of expert oncology clinicians and informaticists has over a decade of experience reviewing the most current oncology clinical evidence and curating the most comprehensive proprietary medical library of treatment plans that include costs, toxicities, expected outcomes, and more. The Eviti Connect for Oncology platform displays all available evidence-based treatment plans filtered by patient-specific data and offers treatment recommendations to providers.

How to Cite


Clarice Holmes, RN 1
The Power of Clinically-Driven Technology and Member-Centric Approaches in Cancer Care – Onco Zine – The International Oncology Network, July 28, 2023.
DOI: 10.14229/onco.2023.08.02.002
1 NantHealth

Advertisement #5